Multiple Approaches to Genetic Sequencing to Identify Hepatitis C Virus Reinfection Among People Who Inject Drugs
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf235 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Kyra H Grantz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Hepacivirus, Hepatitis C, Substance Abuse, Intravenous, Reinfection. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, Johns Hopkins University Center for AIDS Research, National Institute on Drug Abuse.
Abstract (Originalsprache)
The burden of hepatitis C virus (HCV) among persons who inject drugs is determined by dynamics of infection, spontaneous clearance, treatment clearance, treatment failure, and reinfection. We used deep sequencing by Nanopore to study sequences of persons with and without self-reported HCV treatment. Even after years of evolution, sequences from the same person were always more similar than sequences from different persons and a Hamming distance threshold of 0.064 reliably differentiated (AUC 0.999) the groups. By comparison to sequences before treatment, identification of unique sequences (distance > 0.064) after treatment reliably identified 8 of 28 instances of post-treatment reinfection. There were multiple causes for finding the same (distance < 0.064) sequence after intended treatment including not commencing or abbreviating treatment, pharmacological treatment failure, or possibly reinfection from same source. These data underscore the value of HCV sequence analysis in understanding viral dynamics among PWID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
- Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Raghavendran Anantharam, Jeffrey Quinn, Oluwaseun Falade-Nwulia, Javier Cepeda, Amy Wesolowski
Förderung
- NIDA NIH HHS
- Johns Hopkins University Center for AIDS Research
- National Institute on Drug Abuse
Zitieren
APA
Grantz, K. H., Anantharam, R., Kandathil, A. J., Quinn, J., Astemborski, J., Kirk, G. D., Falade-Nwulia, O., Cepeda, J., Thomas, D. L., Mehta, S. H., & Wesolowski, A. (2025). Multiple Approaches to Genetic Sequencing to Identify Hepatitis C Virus Reinfection Among People Who Inject Drugs. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf235
Vancouver
Grantz KH, Anantharam R, Kandathil AJ, Quinn J, Astemborski J, Kirk GD, et al. Multiple Approaches to Genetic Sequencing to Identify Hepatitis C Virus Reinfection Among People Who Inject Drugs. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf235
BibTeX
@article{Grantz2025,
author = {Grantz, Kyra H and Anantharam, Raghavendran and Kandathil, Abraham J and Quinn, Jeffrey and Astemborski, Jacqueline and Kirk, Gregory D and Falade-Nwulia, Oluwaseun and Cepeda, Javier and Thomas, David L and Mehta, Shruti H and Wesolowski, Amy},
title = {Multiple Approaches to Genetic Sequencing to Identify Hepatitis C Virus Reinfection Among People Who Inject Drugs},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf235}
}
EUVIMED